Does MEPOLIZUMAB Cause Flushing? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Flushing have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.2% of all adverse event reports for MEPOLIZUMAB.
84
Reports of Flushing with MEPOLIZUMAB
0.2%
of all MEPOLIZUMAB reports
0
Deaths
36
Hospitalizations
How Dangerous Is Flushing From MEPOLIZUMAB?
Of the 84 reports, 36 (42.9%) required hospitalization, and 21 (25.0%) were considered life-threatening.
Is Flushing Listed in the Official Label?
Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for MEPOLIZUMAB.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which MEPOLIZUMAB Alternatives Have Lower Flushing Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE